Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia.
Chronic myeloid leukemia (CML) is a clonal disorder of the hematopoietic stem cell caused by the BCR-ABL receptor tyrosine kinase. Imatinib mesylate (IM) is an inhibitor of BCR-ABL and has been approved for the treatment of CML. IM is well tolerated and highly efficacious as it induces stable long-t...
Kaydedildi:
Yazar: | |
---|---|
Diğer Yazarlar: | |
Materyal Türü: | Dissertation |
Dil: | İngilizce |
Baskı/Yayın Bilgisi: |
Philipps-Universität Marburg
2011
|
Konular: | |
Online Erişim: | PDF Tam Metin |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
No citations were found for this record.